TickerFiles

AVENUE THERAPEUTICS, INC. 10-Q filing

Filed 2025-11-13 · Report date 2025-09-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001437749-25-034821
Form type
10-Q
CIK
0001644963
Primary document
https://www.sec.gov/Archives/edgar/data/1644963/000143774925034821/atxi20250930_10q.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for AVENUE THERAPEUTICS, INC..

Reported financial metrics

MetricCurrentPriorChange
Revenue$1.4M--
Operating Income$-2.3M--
Net Income$-2.2M--
Eps Basic-0.71--
Cash And Equivalents$3.7M--
Total Assets$3.7M--
Total Liabilities$1.4M--
Shareholders Equity$3.6M--
Operating Cash Flow$-979,000--